Stocks Jones Trading Upgrades Adaptimmune Therapeutics to Buy and Sets a $3 Price Target From Investing.comMarch 7, 2024 On Wednesday, Adaptive immune therapy plc (NASDAQ:) has received a rating upgrade from Jones Trading…
